American College of Clinical Pharmacy
      Search      Cart
         

IDSAP 2022 Book 2 Infections in Critically Ill Patients


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.

Infections in Critically Ill Patients focuses on evidence-based strategies for the management of critically ill patients with infections, covering a variety of topics ranging from antimicrobial stewardship to management of sepsis to pharmacokinetics/pharmacodynamics.

Kayla R. Stover Hielscher, Pharm.D., FCCP, FIDSA, BCIDP, BCPS
Hielscher

The target audience for the book is board-certified infectious diseases pharmacists caring for critically ill patients with infections. Infections in Critically Ill Patients contains four learning modules with a total available 16.0 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Kayla R. Stover Hielscher, Pharm.D., FCCP, FIDSA, BCIDP, BCPS.

The first module of this IDSAP book focus on the management of sepsis and septic shock. Chapters within these modules address the role of anti-infective therapy and supportive management, including fluids, hemodynamic support, and additional therapies. The second module focuses on optimizing drug therapy in these critically ill patients, including chapters related to antimicrobial stewardship and pharmacokinetics/pharmacodynamics with a focus on renal replacement therapy and extracorporeal membrane oxygenation circuits. The third module shifts to management of infections of the central nervous system, with chapters focusing on community-acquired meningitis and iatrogenic CNS infections. The final module provides opportunities for learners to apply optimal stewardship, infection prevention, and treatment principles in interactive cases focused on decreasing blood culture contamination and evaluating shorter durations of therapy in critically ill patients.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Interactive cases (a series of webpages, each introduced by a sample case-based question)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Release Date: November 15, 2022
BCIDP Deadline: May 15, 2023
ACPE Deadline: November 15, 2025

ISBN: 978-1-952291-60-9
Publication Year: 2022
Format: PDF and ePub
Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.